Last reviewed · How we verify

NCT06759402: FIAT

Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)

Recruiting now NA Last updated 13 February 2025
What this trial tests

NA trial testing Family based treatment in Anorexia Nervosa in 200 participants. Currently enrolling.

Timeline
31 January 2025
Primary endpoint
31 March 2027
31 December 2027

Quick facts

Lead sponsorCharite University, Berlin, Germany
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment200
Start date31 January 2025
Primary completion31 March 2027
Estimated completion31 December 2027
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Charite University, Berlin, Germany

Who can join

Adults 8 to 17, any sex, with Anorexia Nervosa or Anorexia in Adolescence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The FIAT study is funded by the Innovationsfonds of the German Ministry of Health via the DLR Project Management Agency. The study will be conducted in up to 21 hospitals across Germany and in collaboration with 10 German public health insurance companies. The primary aim of this study is to compare Family-Based Treatment delivered via telehealth (FBT) with inpatient multimodal therapy (IMT) with respect to treatment outcomes and health economic data. The results of the study will serve as a basis for the decision on the inclusion of FBT in the German S3 guidelines and the future reimbursement of FBT by public health insurances in Germany.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anorexia Nervosa

Currently open trials in the same condition.

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06759402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing